Abstract
Comparative genomic hybridization (CGH) studies have demonstrated a high incidence of chromosomal imbalances in non-Hodgkin's lymphoma. However, the information on the genomic imbalances in Burkitt's Lymphoma (BL) is scanty. Conventional cytogenetics was performed in 34 cases, and long-distance PCR for t(8;14) was performed in 18 cases. A total of 170 changes were present with a median of four changes per case (range 1–22). Gains of chromosomal material (143) were more frequent than amplifications (5) or losses (22). The most frequent aberrations were gains on chromosomes 12q (26%), Xq (22%), 22q (20%), 20q (17%) and 9q (15%). Losses predominantly involved chromosomes 13q (17%) and 4q (9%). High-level amplifications were present in the regions 1q23–31 (three cases), 6p12–p25 and 8p22–p23. Upon comparing BL vs Burkitt's cell leukemia (BCL), the latter had more changes (mean 4.3±2.2) than BL (mean 2.7±3.2). In addition, BCL cases showed more frequently gains on 8q, 9q, 14q, 20q, and 20q, 9q, 8q and 14q, as well as losses on 13q and 4q. Concerning outcome, the presence of abnormalities on 1q (ascertained either by cytogenetics or by CGH), and imbalances on 7q (P=0.01) were associated with a short survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hecht JL, Aster JC . Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000; 18: 3707–3721.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.
Johansson B, Mertens F, Mitelman F . Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995; 86: 3905–3914.
Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–1049.
Johansson B, Mertens F, Mitelman F . Primary vs secondary neoplasia-associated chromosomal abnormalities-balanced rearrangements vs genomic imbalances? Genes Chromosomes Cancer 1996; 16: 155–163.
Bentz M, Huck K, du MS, Joos S, Werner CA, Fischer K et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 1995; 85: 3610–3618.
Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999; 93: 4365–4374.
Bentz M, Werner CA, Dohner H, Joos S, Barth TF, Siebert R et al. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 1996; 88: 1437–1444.
Hernandez JM, Garcia JL, Gutierrez NC, Mollejo M, Martinez-Climent JA, Flores T et al. Novel genomic imbalances in b-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol 2001; 158: 1843–1850.
Monni O, Joensuu H, Franssila K, Knuutila S . DNA copy number changes in diffuse large B-cell lymphoma – comparative genomic hybridization study. Blood 1996; 87: 5269–5278.
Werner CA, Dohner H, Joos S, Trumper LH, Baudis M, Barth TF et al. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol 1997; 151: 335–342.
Hernandez JM, Garcia JL, Gutierrez NC, Mollejo M, Martinez-Climent JA, Flores T et al. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol 2001; 158: 1843–1850.
Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A . Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992; 13: 718–725.
Lichter P, Ried T . Molecular analysis of chromosome aberrations. In situ hybridization. Methods Mol Biol 1994; 29: 449–478.
Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10: 231–243.
Akasaka T, Muramatsu M, Ohno H, Miura I, Tatsumi E, Fukuhara S et al. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms. Blood 1996; 88: 985–994.
Basso K, Frascella E, Zanesco L, Rosolen A . Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomas. Am J Pathol 1999; 155: 1479–1485.
Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–481.
Lichter P, Joos S, Bentz M, Lampel S . Comparative genomic hybridization: uses and limitations. Semin Hematol 2000; 37: 348–357.
Zimonjic DB, Keck-Waggoner C, Popescu NC . Novel genomic imbalances and chromosome translocations involving c-myc gene in Burkitt's lymphoma. Leukemia 2001; 15: 1582–1588.
Zunino A, Viaggi S, Ottaggio L, Fronza G, Schenone A, Roncella S et al. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma. Haematologica 2000; 85: 250–255.
Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB et al. Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma. Br J Cancer 2001; 85: 1900–1913.
Avet-Loiseau H, Vigier M, Moreau A, Mellerin MP, Gaillard F, Harousseau JL et al. Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas. Br J Haematol 1997; 97: 119–122.
Viardot A, Moller P, Hogel J, Werner K, Mechtersheimer G, Ho AD et al. Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. J Clin Oncol 2002; 20: 4523–4530.
Hough RE, Goepel JR, Alcock HE, Hancock BW, Lorigan PC, Hammond DW . Copy number gain at 12q12–14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma. Br J Cancer 2001; 84: 499–503.
Viardot A, Martin-Subero JI, Siebert R, Harder S, Gesk S, Bentz M et al. Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis. Leukemia 2001; 15: 177–183.
Chan WY, Wong N, Chan AB, Chow JH, Lee JC . Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach. Am J Pathol 1998; 152: 11–16.
Karhu R, Knuutila S, Kallioniemi OP, Siltonen S, Aine R, Vilpo L et al. Frequent loss of the 11q14–24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group. Genes Chromosomes Cancer 1997; 19: 286–290.
Rickert CH, Dockhorn-Dworniczak B, Simon R, Paulus W . Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol 1999; 155: 1445–1451.
Autio K, Aalto Y, Franssila K, Elonen E, Joensuu H, Knuutila S . Low number of DNA copy number changes in small lymphocytic lymphoma. Haematologica 1998; 83: 690–692.
Joos S, Otano-Joos MI, Ziegler S, Bruderlein S, du MS, Bentz M et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87: 1571–1578.
Barth TF, Dohner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M et al. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998; 91: 4321–4330.
Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S . BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 1997; 90: 1168–1174.
Rao PH, Houldsworth J, Dyomina K, Parsa N, Cigudosa JC, Louie D et al. Chromosomal and gene amplifications in diffuse large B-cell lymphoma. Blood 1998; 92: 234–240.
Mohamed AN, Palutke M, Eisenberg L, Al Katib A . Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant. Cancer Genet Cytogenet 2001; 126: 45–51.
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.
Aalto Y, Nordling S, Kivioja AH, Karaharju E, Elomaa I, Knuutila S . Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma. Genes Chromosomes Cancer 1999; 25: 104–107.
Avet-Loiseau H, Andree-Ashley LE, Moore D, Mellerin MP, Feusner J, Bataille R et al. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer 1997; 19: 124–133.
Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michaeli J, Jhanwar SC et al. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization [see comments]. Blood 1998; 91: 3007–3010.
Gutierrez NC, Hernandez JM, Garcia JL, Canizo MC, Gonzalez M, Hernandez J et al. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia 2001; 15: 840–845.
McDonald HL, Gascoyne RD, Horsman D, Brown CJ . Involvement of the X chromosome in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2000; 28: 246–257.
Bentz M, Barth TF, Bruderlein S, Bock D, Schwerer MJ, Baudis M et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B- cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001; 30: 393–401.
Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK . Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991; 77: 1508–1515.
Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L et al. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 1997; 11: 747–758.
Schlegelberger B, Zwingers T, Harder L, Nowotny H, Siebert R, Vesely M et al. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel–Wien-Lymphoma Study Group. Blood 1999; 94: 3114–3120.
Knutsen T . Cytogenetic changes in the progression of lymphoma. Leukemia Lymphoma 1998; 31: 1–19.
Acknowledgements
We appreciate the technical support of E Lumbreras, Ma Garcia Granero, M Anderson, P Fernández, MA Hernández, A Simón and A Crego.
Author information
Authors and Affiliations
Additional information
This work was partially supported by Grants of Spanish FIS (01/3153; 02/1358 & 02/1041).
Rights and permissions
About this article
Cite this article
García, J., Hernandez, J., Gutiérrez, N. et al. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study. Leukemia 17, 2016–2024 (2003). https://doi.org/10.1038/sj.leu.2403080
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403080
Keywords
This article is cited by
-
Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia
Leukemia (2018)
-
Intracellular Signaling Pathways Involved in Childhood Acute Lymphoblastic Leukemia; Molecular Targets
Indian Journal of Hematology and Blood Transfusion (2016)
-
MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
Infectious Agents and Cancer (2013)
-
A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility
Oncogene (2011)
-
Secondary abnormalities involving 1q or 13q and poor outcome in high stage Burkitt leukemia/lymphoma cases with 8q24 rearrangement at diagnosis
International Journal of Hematology (2011)